Skip to main content
. 2023 Sep 22;12(19):6124. doi: 10.3390/jcm12196124
SCV single chain of variable fragment
LDC lymphodepletion chemotherapy
CRS cytokine release syndrome
ICANS immune-effector-cell-associated neurotoxicity syndrome
IFN-γ interferon-gamma
IL-6 interleukin-6
TNF-α tumor necrosis factor-alpha
GM-CSF granulocyte–macrophage colony-stimulating factor
APCs antigen-presenting cells
DCs dendritic cells
CD40L ligand for CD40
DAMPs danger-associated molecular patterns
PT prothrombin time
PPT partial thromboplastin time
HLH hemophagocytic lymph histiocytosis
ASTCT American Society for Transplantation and Cellular Therapy
BBB blood–brain barrier
CNS central nervous system
TLS tumor lysis syndrome
BCMA B cell maturation antigen
CLS capillary leak syndrome
OTOT on-target, off-tumor toxicity
TAAs tumor-associated antigens
TSAs tumor-specific antigens
CBC complete blood count
CRP C-reactive protein
LDH lactate dehydrogenase
ECG electrocardiogram
sICAM soluble intercellular adhesion molecule
sVCAM soluble vascular cell adhesion molecule
FOLR1 folate receptor 1
TAG72 tumor-associated glycoprotein 72
IL-6R interleukin-6 receptor
i.v. intravenous injection
ICP intracranial pressure